sars cov 2 — grants

Sort

8,912 grants matching “sars cov 2”

The tale of two pandemics: Understanding racial and ethnic disparities from the collision of HIV and COVID-19 in the U.S.

$722,272

Rena Chiman Patel · University Of Washington · R01 · FY2022 · MH

Advancing the development of a novel class of small molecules for treating pan-coronavirus infections

$721,967

Shirit Einav · Stanford University · R01 · FY2022 · AI

Factors influencing TRM responses in upper airway tissue

$721,915

Pandurangan Vijayanand · La Jolla Institute For Immunology · U19 · FY2024 · AI

Role of mitochondrial extracellular vesicles in CVB3 myocarditis by sex

$721,646

Delisa Fairweather · Mayo Clinic Jacksonville · R01 · FY2025 · HL

Determinants of COVID19-induced venous thrombosis and targeted therapy assessed with bioengineered vein-chip

$721,633

John H Connor · Boston University Medical Campus · R01 · FY2021 · HL

Maternal SARS-CoV-2 infection, placenta biology, and neurodevelopmental outcomes in the offspring

$721,393

Gianluca Ursini · Lieber Institute, Inc. · R01 · FY2023 · HD

Understanding the long term impact of COVID-19 on the brain through advanced MR imaging and spectroscopy

$721,322

Gulin Oz · University Of Minnesota · R01 · FY2021 · NS

Combined adjuvant approaches for enhancement of SARS-CoV-2 vaccine efficacy

$721,321

Pamela Tinmoi Wong · University Of Michigan At Ann Arbor · R01 · FY2025 · AI

Using Disadvantage Indices to Address Structural Racism and Discrimination in Pandemic Vaccine Allocation and Beyond: Defining the Shape of a Novel Paradigm to Promote Health Equity

$721,177

Thomas Harald Schmidt · University Of Pennsylvania · R01 · FY2022 · AI

Pre-Existing Atopy and Respiratory Viral Infections

$721,121

Mitchell H Grayson · Research Inst Nationwide Children'S Hosp · R01 · FY2024 · AI

Molecular pathogenesis of COVID-19-associated coagulopathy and new therapeutic approaches

$720,351

Roberto Aiolfi · Scripps Research Institute, The · R01 · FY2024 · HL

Uncover mechanisms underlying the development of chronic lung sequelae post COVID-19

$720,284

Jie Sun · University Of Virginia · R01 · FY2023 · HL

LatiNET, a Multilevel Social Network Model to Examine and Address SARS-CoV-2 Misinformation in Low-Income Latinx Communities.

$719,232

Mariano Juan Kanamori Nishimura · University Of Miami School Of Medicine · R01 · FY2024 · MD

DREAM Sentinels: Selection of aptamers that target viral variants with high specificity

$718,956

Hsin-Chih Yeh · University Of Texas At Austin · · FY2023 · ENG

Coronavirus Pathogenesis and Broadly Protective Vaccine Development

$718,928

Matthew Memoli · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI

A smartphone-based rapid point-of-care test for SARS-CoV-2 detection from respiratory samples

$718,866

Andrew Slator Paterson · Luminostics, Inc. · R44 · FY2020 · AI

Non-conventional signaling by Î±5 integrin in blood and endothelial cells

$718,854

Jieqing Zhu · Versiti Blood Health, Inc. · R01 · FY2025 · HL

Non-conventional signaling by Î±5 integrin in blood and endothelial cells

$718,854

Jieqing Zhu · Versiti Wisconsin, Inc. · R01 · FY2024 · HL

Engineering protease-resistant antiviral peptide inhibitors for SARS-CoV-2

$718,692

Anne Moscona · Columbia University Health Sciences · R01 · FY2023 · AI

Inhalation Therapy Platform for Coronavirus Infection Treatment

$718,653

Patrick S. Stayton · University Of Washington · R01 · FY2024 · AI

Brain signature of SARS-CoV-2 Infection and its impact on long-term cognitive functioning in older adults

$718,089

Giovanni Schifitto · University Of Rochester · R01 · FY2025 · AG

Developing a Multi-epitope Pan-Coronavirus Vaccine

$717,976

Lbachir Benmohamed · University Of California-Irvine · R01 · FY2021 · AI

The tale of two pandemics: Understanding racial and ethnic disparities from the collision of HIV and COVID-19 in the U.S.

Advancing the development of a novel class of small molecules for treating pan-coronavirus infections

Factors influencing TRM responses in upper airway tissue

Role of mitochondrial extracellular vesicles in CVB3 myocarditis by sex

Determinants of COVID19-induced venous thrombosis and targeted therapy assessed with bioengineered vein-chip

Maternal SARS-CoV-2 infection, placenta biology, and neurodevelopmental outcomes in the offspring

Understanding the long term impact of COVID-19 on the brain through advanced MR imaging and spectroscopy

Combined adjuvant approaches for enhancement of SARS-CoV-2 vaccine efficacy

Using Disadvantage Indices to Address Structural Racism and Discrimination in Pandemic Vaccine Allocation and Beyond: Defining the Shape of a Novel Paradigm to Promote Health Equity

Pre-Existing Atopy and Respiratory Viral Infections

Molecular pathogenesis of COVID-19-associated coagulopathy and new therapeutic approaches

Uncover mechanisms underlying the development of chronic lung sequelae post COVID-19

Low Density Neutrophils Link Inflammation and Coagulopathy in COVID-19

Inborn errors of immunity in patients with life-threatening COVID-19

Proteomics-Driven Reverse Vaccinology for Gonorrhea

LatiNET, a Multilevel Social Network Model to Examine and Address SARS-CoV-2 Misinformation in Low-Income Latinx Communities.

DREAM Sentinels: Selection of aptamers that target viral variants with high specificity

Coronavirus Pathogenesis and Broadly Protective Vaccine Development

A smartphone-based rapid point-of-care test for SARS-CoV-2 detection from respiratory samples

Non-conventional signaling by Î±5 integrin in blood and endothelial cells

Non-conventional signaling by Î±5 integrin in blood and endothelial cells

Engineering protease-resistant antiviral peptide inhibitors for SARS-CoV-2

Inhalation Therapy Platform for Coronavirus Infection Treatment

Brain signature of SARS-CoV-2 Infection and its impact on long-term cognitive functioning in older adults

Developing a Multi-epitope Pan-Coronavirus Vaccine